Liquid Embolics for Peripheral Embolization

Tuesday, March 7, 2023

1:00 PM – 2:30 PM

Location:Phoenix Convention Center, 221AB

CE: 1.5 Credits

Coordinator(s)

Abhishek Kumar, MD

Chief, Vascular and Interventional Radiology
Rutgers New Jersey Medical School

Disclosure(s): Boston Scientific: Consultant (Ongoing), Speaking and Teaching (Ongoing); NAKI Therapeuatics: Advisory Committee or Review Panel Member (Ongoing)
Sanjeeva Kalva, MD, FSIR, FCIRSE, FACR (he/him/his)

Professor
Massachusetts General Hospital

Disclosure(s): BD Bard: Consultant (Ongoing); Biogen Inc, Clover Health Investments Corp, Inovio Pharmaceuticals, Moderna Inc, Pfizer Inc, Novavax Inc, Orphazyme, Cassava Sciences Inc, Vivos Therapeutics Inc, Ardelyx Inc, Althea Health, Sarepta Therapeutics, Clover Health Investments Corp, CureV: Ownership Interest (Ongoing), Stocks (Ongoing); Boston Scientific Corp: Consultant (Ongoing); Canon Medical: Consultant (Ongoing), Speaking and Teaching (Ongoing); Covidien/Medtronic: Consultant (Ongoing); Instylla, Inc.: Consultant (Ongoing); Okami Medical: Consultant (Ongoing); Penumbra Inc.: Consultant (Terminated), Speaking and Teaching (Terminated); Sirtex Medical: Consultant (Ongoing); Varian: Consultant (Ongoing)

Disclosure(s):

Abhishek Kumar, MD: Boston Scientific: Consultant (Ongoing), Speaking and Teaching (Ongoing); NAKI Therapeuatics: Advisory Committee or Review Panel Member (Ongoing)

Sanjeeva Kalva, MD, FSIR, FCIRSE, FACR: BD Bard: Consultant (Ongoing); Biogen Inc, Clover Health Investments Corp, Inovio Pharmaceuticals, Moderna Inc, Pfizer Inc, Novavax Inc, Orphazyme, Cassava Sciences Inc, Vivos Therapeutics Inc, Ardelyx Inc, Althea Health, Sarepta Therapeutics, Clover Health Investments Corp, CureV: Ownership Interest (Ongoing), Stocks (Ongoing); Boston Scientific Corp: Consultant (Ongoing); Canon Medical: Consultant (Ongoing), Speaking and Teaching (Ongoing); Covidien/Medtronic: Consultant (Ongoing); Instylla, Inc.: Consultant (Ongoing); Okami Medical: Consultant (Ongoing); Penumbra Inc.: Consultant (Terminated), Speaking and Teaching (Terminated); Sirtex Medical: Consultant (Ongoing); Varian: Consultant (Ongoing)

This session will provide an overview of currently available liquid embolic materials. The session is case-based.

Learning Objectives:

Discuss various liquid embolic materials for vascular and nonvascular occlusion
Review the practical aspects and limitations of various liquid embolic materials
Review complications of liquid embolotherapy

Presentations:

1:00 PM – 1:15 PM

Liquid embolic materials for embolization
Speaker: Sanjeeva Kalva, MD, FSIR, FCIRSE, FACR (he/him/his) – Massachusetts General Hospital
1:15 PM – 1:30 PM

Liquids for Bleeding
Speaker: Dan Shilo, MD – Mount Sinai Hospital
1:30 PM – 1:45 PM

Liquids for Endoleaks/AVMs
Speaker: Luke R. Wilkins, MD, FSIR – University of Virginia
1:45 PM – 2:00 PM

Liquids Tumor/Tissue embolization (AML, Splenic, HCC, etc.)
Speaker: Daniel B. Brown, M.D. – Vanderbilt University Medical Center
2:00 PM – 2:15 PM

Liquids for Venous embolization
Speaker: Abhishek Kumar, MD – Rutgers New Jersey Medical School
2:15 PM – 2:30 PM

Liquids for Lymphatics
Speaker: Sara Smolinski-Zhao, MD (she/her/hers) – Massachusetts General Hospital